angiotensin ii has been researched along with daunorubicin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brücher, C; Spinelli, F | 1 |
| Aizawa, Y; Arozal, W; Kodama, M; Ma, M; Sukumaran, V; Suzuki, K; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K | 1 |
2 other study(ies) available for angiotensin ii and daunorubicin
| Article | Year |
|---|---|
Structural changes of the podocytes in different states of experimentally induced proteinuria in the rat.
Topics: Angiotensin II; Animals; Daunorubicin; Kidney Glomerulus; Microscopy, Electron, Scanning; Oxygen; Proteinuria; Rats; Serum Albumin | 1975 |
Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antioxidants; Benzimidazoles; Benzoates; Daunorubicin; Gene Expression Regulation; Kidney; Kidney Diseases; Kidney Function Tests; Male; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Telmisartan | 2011 |